Rearming the body’s immune system to fight cancer
We’re developing more precise and more accessible treatment alternatives for patients with solid cancers
Pioneering excellence in the field of immunotherapy
Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer.
Some of our partners
Latest news
The Beautiful Cure’ Reveals The ‘Profound’ Power Of The Immune System
By Christine Filippis / November 29, 2018
An interview with UK immunologist Daniel Davis on national Public Radio's "Fresh Air" is a good discussion about his new...
Read More
Cartherics Corporate Adviser Dr Ian Nisbet talks about ‘what pisses him off’
By Christine Filippis / November 22, 2018
WHAT PISSES ME OFF When it comes to taking ideas to market, Corporate Advisor Ian Nisbet says America’s entrepreneurial ethos...
Read More
Communications Adviser Leigh Dayton talks to Cartherics Scientific Board member Jacques Miller – the man who discovered the function of the thymus gland yet didn’t win the Nobel Prize.
By Christine Filippis / November 9, 2018
IMMUNOLOGIST Jacques Miller did not win this year’s Nobel Prize in Physiology or Medicine. He didn’t win it last year...
Read More
